Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects
- Resource Type
- Article
- Source
- In
International Journal of Pharmaceutics 15 June 2016 506(1-2):268-279 - Subject
- Language
- ISSN
- 0378-5173